Sign In

Communications of the ACM

ACM News

Fred Hutch, Amazon Collaborating on Clinical Trial to Test Vaccines Against Cancer

The Arnold Building on the Fred Hutchinson Cancer Research Center campus.

Neither Fred Hutch or Amazon would clarify their financial or intellectual property relationship. The vaccine trial also will assess anti-tumor response and survival as secondary outcome measurements.

Credit: Fred Hutch

Fred Hutchinson Cancer Center is leveraging Amazon's machine learning expertise to collaborate on an early-stage clinical trial testing an anti-cancer vaccine in patients with certain types of breast cancer or melanoma.

The trial was posted on a government clinical trial database in October and will explore the safety of the vaccine, which will be personalized for patients with late-stage melanoma or metastatic breast cancer that does not have the marker HER2.

Business Insider first reported on the trial Monday, and Amazon and Fred Hutch verified the collaboration with GeekWire. Fred Hutch is leading the effort and Amazon is a partner.

From GeekWire
View Full Article



No entries found

Sign In for Full Access
» Forgot Password? » Create an ACM Web Account